Filing Details

Accession Number:
0001493152-23-020333
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-06 21:00:08
Reporting Period:
2023-06-02
Accepted Time:
2023-06-06 21:00:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1841330 Pasithea Therapeutics Corp. KTTA () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1132679 Lawrence Steinman 1111 Lincoln Road, Suite 500
Miami Beach FL 33139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-06-02 30,000 $0.43 1,327,174 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.38 to $0.45 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.